Arcellx, Inc. - ACLX
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q2 2026
· Q1 2026
Value (USD)
Total reported value ($000)
$50.1M
QoQ value delta ($000)
-$6.58B
(-99.24%)
Implied price effect (QoQ)
+0.42%
Shares
Total shares
436,479
QoQ shares delta
-57,573,352
(-99.25%)
Total shares held by funds (by quarter)
Market chart (ACLX)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q2 2026)
Top 25 only
Full list
Partial Q2 2026 data: 2 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 25,660 | 223,486 | 84.07% |
| JANUS HENDERSON GROUP PLC | 10,367 | 90,280 | 0.0% |
| CIBRA Capital Ltd | 10,175 | 88,623 | 4.91% |
| DekaBank Deutsche Girozentrale | 3,430 | 30,000 | 0.01% |
| BCK CAPITAL MANAGEMENT LP | 459 | 4,000 | 2.0% |
| CWM, LLC | 8 | 77 | 0.0% |
| IFP Advisors, Inc | 1 | 13 | 0.0% |